← FDA Drug Approvals (Drugs@FDA)
TYENNE
BLA · Biologics License Application · Sponsor: FRESENIUS KABI USA · Approved 2024-03-05
Drug application
- FDA Application #
BLA761275- Application type
- Biologics License Application
- Brand name
- TYENNE
- Generic name
- TOCILIZUMAB-AAZG
- Active ingredients
- TOCILIZUMAB-AAZG
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- FRESENIUS KABI USA
- Manufacturer
- Fresenius Kabi USA, LLC
- First approval
- 2024-03-05
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown